Dr. Chen
Co - founder of senior VP of biology
Pharmaceuticals
Abbisko Therapeutics
China
Biography
Dr. Chen is an experienced biologist who has more than ten years of experience in the discovery and development of new drugs, and has participated in a number of new drug research and development projects ranging from early drug target selection and new drug screening optimization to transformation research and clinical research. Including the FDA-approved heavy drug BCL-2 inhibitor Venetoclax (ABT-199). Prior to co-creation and reputation, Dr. Chen was a researcher at the R & D Center for Research and Development of Hepatocellular Carcinoma in China's R & D Center in China, as well as a director of research and development of lung cancer drugs, a researcher at Novartis China R & D Center - research and development of new drugs in the field of epigenetics Cancer Transformation
Research Interest
Business, Management, Finance, Pharmaceuticals, Chemistry, Pharmacology
